North America Autotransfusion Devices Market to 2027 - Regional Analysis and Forecasts by Type (Product, Accessories); Application (Cardiac Surgeries, Orthopaedic Surgeries, Organ Transplantation, Trauma Procedures, Others); End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers); and Country
The North America autotransfusion devices market is expected anticipated to reach US$ 430.62 Mn in 2027 from US$ 305.15 Mn in 2019. The market is estimated to grow with a CAGR of 4.5% from 2019-2027.
The growth of the market is driven by factors such as the involvement of rare blood groups, rising number of transplant procedures, and rising prevalence of chronic diseases in the North America region. Whereas, risks associated with autotransfusion is likely to have a negative impact on the growth of the market in the coming years.
The autotransfusion process involves the reinfusion of the patient's blood. Blood is collected from the peritoneal cavity or thorax region. The process can be carried out before surgery or during and after the surgery using the autotransfusion system. Medical procedures, like joint replacement, spinal surgeries, and cardiac, among others, require autotransfusion. It helps to reduce the risk of infection, and also it eliminates the problems and complications associated with the banking and administration of homologous donor blood. It helps to prevent the transmission of transfusion-related blood-borne diseases in patients.
The autotransfusion systems are widely used in various surgical procedures such as cardiac surgery, trauma procedures, orthopedic procedures, and other invasive procedures. These procedures are followed by excessive blood loss, and it is difficult to obtain blood of rare group in emergency cases. Autotransfusion system facilitates to reinfuse the patient’s blood back into the body after the due filtration process.
For instance, in the US blood group AB positive is among the rarely found blood group about 196.94 million (0.6%) of the population in 2019 in such cases of rare blood group is difficult to arrange in case if urgent equipment during surgical procedures. Thus, the autotransfusion system is one of the procedures useful for patients with rare blood groups, where the patient’s blood is reinfused in the body. This can be done efficiently with use of appropriate type of autotransfusion devices. Owing to these facts, the cases of involvement of rare blood group are likely to boost the market in the coming years.
The need for reinfusion of blood and robust advancements in healthcare facilities and infrastructure in North America is expected to drive autotransfusion devices market the growing in the country create a lucrative opportunity and the presence of an established market for autotransfusion devices.
Mexico Autotransfusion devices Market Revenue and Forecasts to 2027 (US$ Bn)
Get more information on this report :
NORTH AMERICA AUTOTRANSFUSION DEVICES– MARKET SEGMENTATION
By Type
- Product
- Intraoperative Autotransfusion Systems
- Postoperative Autotransfusion Systems
- Dual-Mode Autotransfusion Systems
- Accessories
By Application
- Cardiac Surgeries
- Orthopaedic Surgeries
- Organ Transplantation
- Trauma Procedures
- Others
By End-Users
- Hospitals
- Specialty Clinics
- Ambulatory Surgery Centers
By Countries
- US
- Canada
- Mexico
Companies Mentioned
- BD
- Braile Biomedica
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- LivaNova PLC
- Medtronic
- Redax S.p.A.
- SARSTEDT AG and Co. KG
- Teleflex Incorporated
- Zimmer Biomet
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Autotransfusion Devices Market – By Type
1.3.2 North America Autotransfusion Devices Market – By Application
1.3.3 North America Autotransfusion Devices Market – By End User
1.3.4 North America Autotransfusion Devices Market – By Country
2. North America Autotransfusion Devices Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Autotransfusion Devices Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 4.2.1 Autotransfusion Devices Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Autotransfusion Devices Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Involvement of rare blood groups
5.1.2 Rising number of transplant procedures
5.1.3 Rising prevalence of chronic diseases
5.2 Key Restraints
5.2.1 Risks associated with autotransfusion
5.3 Key Market Opportunities
5.3.1 Robust Advancements in Healthcare Facilities and Infrastructure
5.4 Future Trend
5.4.1 Need for reinfusion of blood
5.5 Impact Analysis
6. Autotransfusion Devices Market – North America Analysis
6.1 North America Autotransfusion Devices Market Revenue Forecasts and Analysis
6.2 Positioning of Key Players
7. North America Autotransfusion Devices Market Analysis And Forecasts To 2027 – By Type
7.1 Overview
7.2 North America Autotransfusion Devices Market, By Type 2019 & 2027 (%)
7.2.1 North America Autotransfusion Devices Market Revenue and Forecasts to 2027, By Type (US$ Mn)
7.3 Products
7.3.1 Overview
7.3.2 North America Products Market Revenue and Forecast to 2027 (US$ Mn)
7.3.3 Intraoperative Autotransfusion Systems
7.3.3.1 Overview
7.3.3.2 North America Intraoperative Autotransfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.4 Postoperative Autotransfusion Systems
7.3.4.1 Overview
7.3.4.2 North America Postoperative Autotransfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.5 Dual-mode Autotransfusion Systems
7.3.5.1 Overview
7.3.5.2 North America Dual-mode Autotransfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Accessories
7.4.1 Overview
7.4.2 North America Accessories Market Revenue and Forecast to 2027 (US$ Mn)
8. North America Autotransfusion Devices Market Analysis– By Application
8.1 Overview
8.2 North America Autotransfusion Devices Market, By Application 2019-2027 (%)
8.2.1 North America Autotransfusion Devices Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Cardiac Surgeries
8.3.1 Overview
8.3.2 North America Cardiac Surgeries Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Orthopaedic Surgeries
8.4.1 Overview
8.4.2 North America Orthopaedic Surgeries Size Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Organ Transplantation
8.5.1 Overview
8.5.2 North America Organ Transplantation Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Trauma Surgery Procedures
8.6.1 Overview
8.6.2 North America Trauma Surgery Procedures Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Others
8.7.1 Overview
8.7.2 North America Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Autotransfusion Devices Market Analysis– By End-User
9.1 Overview
9.2 North America Autotransfusion Devices Market, By End-User 2019 & 2027 (%)
9.2.1 North America Autotransfusion Devices Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
9.3 Hospitals
9.3.1 Overview
9.3.2 North America Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Specialty Clinics
9.4.1 Overview
9.5 Ambulatory Surgery Centers
9.5.1 Overview
10. Autotransfusion Devices Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 North America Autotransfusion Devices Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 North America: Autotransfusion Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Autotransfusion Devices Market, by Type, 2018–2027 (USD Million)
10.1.3.1 North America: Autotransfusion Devices Market, by Product, 2018–2027 (USD Million)
10.1.4 North America: Autotransfusion Devices Market, by Application, 2018–2027 (USD Million)
10.1.5 North America: Autotransfusion Devices Market, by End User, 2018–2027 (USD Million)
10.1.6 North America: Autotransfusion Devices Market, by Country, 2019 & 2027 (%)
10.1.7 US: Autotransfusion Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Autotransfusion Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Autotransfusion Devices Market, by Type, 2018–2027 (USD Million)
10.1.7.2.1 US: Autotransfusion Device Market, by Product, – 2018–2027 (USD Million)
10.1.7.3 US: Autotransfusion Devices Market, by Application, 2018–2027 (USD Million)
10.1.7.4 US: Autotransfusion Devices Market, by End User, 2018–2027 (USD Million)
10.1.8 Canada: Autotransfusion Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Autotransfusion Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Autotransfusion Devices Market, by Type, 2018–2027 (USD Million)
10.1.8.2.1 Canada: Autotransfusion Device Market, by Product, 2018–2027 (USD Million)
10.1.8.3 Canada: Autotransfusion Devices Market, by Application, 2018–2027 (USD Million)
10.1.8.4 Canada: Autotransfusion Devices Market, by End User, 2018–2027 (USD Million)
10.1.9 Mexico: Autotransfusion Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Autotransfusion Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Autotransfusion Devices Market, by Type, 2018–2027 (USD Million)
10.1.9.2.1 Mexico: Autotransfusion Devices Market, by Product, 2018–2027 (USD Million)
10.1.9.3 Mexico: Autotransfusion Devices Market, by Application, 2018–2027 (USD Million)
10.1.9.4 Mexico: Autotransfusion Devices Market, by End User, 2018–2027 (USD Million)
11. North America Autotransfusion Devices Market Industry Landscape
11.1 Overview
11.1.1 Recent Developments by Players in Autotransfusion Devices Market
12. Autotransfusion Devices Market – Key Company Profiles
12.1 Medtronic
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Fresenius SE & Co. KGaA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Teleflex Incorporated
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BD
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Zimmer Biomet
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Braile Biomedica
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Haemonetics Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Sarstedt AG and Co. KG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 LivaNova PLC
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Redax S.p.A.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Autotransfusion Devices Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 2. North America Autotransfusion Devices Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. North America Autotransfusion Devices Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 1. North America: Autotransfusion Devices Market, by Type, 2018–2027 (USD Million)
Table 2. North America: Autotransfusion Devices Market, by Product, 2018–2027 (USD Million)
Table 3. North America: Autotransfusion Devices Market, by Application, 2018–2027 (USD Million)
Table 4. North America: Autotransfusion Devices Market, by End User, 2018–2027 (USD Million)
Table 5. US: Autotransfusion Devices Market, by Type, 2018–2027 (USD Million)
Table 6. US: Autotransfusion Device Market, by Product, – 2018–2027 (USD Million)
Table 7. US: Autotransfusion Devices Market, by Application, 2018–2027 (USD Million)
Table 8. US: Autotransfusion Devices Market, by End User, 2018–2027 (USD Million)
Table 9. Canada: Autotransfusion Devices Market, by Type, 2018–2027 (USD Million)
Table 10. Canada: Autotransfusion Device Market, by Product, 2018–2027 (USD Million)
Table 11. Canada: Autotransfusion Devices Market, by Application, 2018–2027 (USD Million)
Table 12. Canada: Autotransfusion Devices Market, by End User, 2018–2027 (USD Million)
Table 13. Mexico: Autotransfusion Devices Market, by Type, 2018–2027 (USD Million)
Table 14. Mexico: Autotransfusion Devices Market, by Product, 2018–2027 (USD Million)
Table 15. Mexico: Autotransfusion Devices Market, by Application, 2018–2027 (USD Million)
Table 16. Mexico: Autotransfusion Devices Market, by End User, 2018–2027 (USD Million)
Table 17. Recent Developments in the Autotransfusion Devices market
Table 18. Glossary of Terms, Autotransfusion Devices Market
LIST OF FIGURES
Figure 1. Autotransfusion Devices Market Segmentation
Figure 2. North America Autotransfusion Devices Market Overview
Figure 3. Accessories Segment Held Largest Share of Type Segment in Autotransfusion Devices Market
Figure 4. US Is Expected To Show Remarkable Growth During The Forecast Period
Figure 5. North America Autotransfusion Devices Market- Leading Country Markets (US$ Mn)
Figure 6. Autotransfusion Devices Market - North America PEST Analysis
Figure 7. Autotransfusion Devices Market Impact Analysis of Drivers and Restraints
Figure 8. North America Autotransfusion Devices Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Market Positioning of Key Players in North America Autotransfusion Devices Market
Figure 10. North America Autotransfusion Devices Market, By Type 2019 & 2027 (%)
Figure 11. North America Products Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Intraoperative Autotransfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Postoperative Autotransfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. North America Dual-mode Autotransfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. North America Accessories Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. North America Autotransfusion Devices Market, by Application 2019 & 2027 (%)
Figure 17. North America Cardiac Surgeries Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Orthopaedic Surgeries Size Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. North America Organ Transplantation Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America Trauma Surgery Procedures Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America Autotransfusion Devices Market, By End-User 2019 & 2027 (%)
Figure 23. North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. North America Specialty Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. North America Ambulatory Surgical Centers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. North America: Autotransfusion Devices Market, by Key Country – Revenue (2019) (USD Million)
Figure 27. North America Autotransfusion Devices Market Revenue and Forecast to 2027 (USD Million)
Figure 28. North America: Autotransfusion Devices Market, by Country, 2019 & 2027 (%)
Figure 29. US: Autotransfusion Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Canada: Autotransfusion Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Mexico: Autotransfusion Devices Market – Revenue and Forecast to 2027 (USD Million)
The List of Companies - North America Autotransfusion Devices Market
- BD
- Braile Biomedica
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- LivaNova PLC
- Medtronic
- Redax S.p.A.
- SARSTEDT AG and Co. KG
- Teleflex Incorporated
- Zimmer Biomet
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America autotransfusion devices market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America autotransfusion devices market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.